In tumour microenvironments, cancer cells increase B7-H4 expression in response to hypoxia and transforming growth factor β1 (TGFβ1) [45,46]; IL-6 and IL-10 can also stimulate B7-H4 mRNA expression in macrophages [47]. This evidence concerns the gene VTCN1 and cancer.